Advertisement

Incidence and implications of acute kidney injury in patients hospitalized with acute decompensated heart failure

  • Rajkumar DoshiEmail author
  • Tania Dhawan
  • Casey Rendon
  • Marines Acevedo Rodriguez
  • Jaafar F. Al-khafaji
  • Mohamed Taha
  • Thi Thi Win
  • Nageshwara Gullapalli
IM - ORIGINAL
  • 19 Downloads

Abstract

Acute kidney injury (AKI) is a common complication in patients hospitalized with heart failure (HF). There is a paucity of research on the incidence and consequences of AKI among patients hospitalized with HF who do not have evidence of chronic kidney disease (CKD). The National Inpatient Sample database was used to identify index hospitalizations for acute HF from January 2012 through September 2015. The incidence of new-onset AKI was determined, and the study population was divided into two groups: HF with AKI (HFwAKI) and HF without AKI (HFwoAKI). These groups were further divided into the subgroups HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF). A total of 2,010,095 index hospitalizations for HF were identified. The incidence of new-onset AKI was found to be ~ 20% for this population. In a fully adjusted model, in-hospital mortality was higher in the HFwAKI group (adjusted OR 3.63, P ≤ 0.001) and higher among patients with HFrEF (adjusted OR 3.85), as opposed to patients with HFpEF (adjusted OR 3.21). Similarly, length of stay and cost of care for the HFwAKI group were significantly higher as well. New-onset AKI among hospitalizations for HF poses a significant health problem, especially considering the increasing prevalence of HF. Further research into the causes of AKI among HF hospitalizations is, therefore, important as it will enable the development of treatment strategies to prevent AKI in HF hospitalizations and, consequently, benefit both the patients and health care system of the United States.

Keywords

New-onset acute kidney injury Incidence In-hospital mortality Heart failure 

Notes

Compliance with ethical standards

Conflict of interest

The authors have nothing to disclose.

Statements on human and animal rights

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

For this type of study, formal consent is not required.

References

  1. 1.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jimenez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER III, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB, American Heart Association Statistics C, Stroke Statistics S (2016) Heart disease and stroke statistics-2016 update: a report from the american heart association. Circulation 133(4):e38–360.  https://doi.org/10.1161/CIR.0000000000000350 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Jackson SL, Tong X, King RJ, Loustalot F, Hong Y, Ritchey MD (2018) National burden of heart failure events in the United States, 2006 to 2014. Circ Heart Fail 11(12):e004873.  https://doi.org/10.1161/CIRCHEARTFAILURE.117.004873 CrossRefPubMedGoogle Scholar
  3. 3.
    Vigen R, Maddox TM, Allen LA (2012) Aging of the United States population: impact on heart failure. Curr Heart Fail Rep 9(4):369–374.  https://doi.org/10.1007/s11897-012-0114-8 CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Pina IL, Trogdon JG, American Heart Association Advocacy Coordinating C, Council on Arteriosclerosis T, Vascular B, Council on Cardiovascular R, Intervention, Council on Clinical C, Council on E, Prevention, Stroke C (2013) Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 6(3):606–619.  https://doi.org/10.1161/HHF.0b013e318291329a CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics C, Stroke Statistics S (2017) Heart disease and stroke statistics-2017 update: a report from the american heart association. Circulation 135(10):e146–e603.  https://doi.org/10.1161/CIR.0000000000000485 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hata N, Yokoyama S, Shinada T, Kobayashi N, Shirakabe A, Tomita K, Kitamura M, Kurihara O, Takahashi Y (2010) Acute kidney injury and outcomes in acute decompensated heart failure: evaluation of the RIFLE criteria in an acutely ill heart failure population. Eur J Heart Fail 12(1):32–37.  https://doi.org/10.1093/eurjhf/hfp169 CrossRefPubMedGoogle Scholar
  7. 7.
    Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S (2016) Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol 12(10):610–623.  https://doi.org/10.1038/nrneph.2016.113 CrossRefPubMedGoogle Scholar
  8. 8.
    Damman K, Testani JM (2015) The kidney in heart failure: an update. Eur Heart J 36(23):1437–1444.  https://doi.org/10.1093/eurheartj/ehv010 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Whalen D, Houchens R, Elixhauser A (2007) HCUP Nationwide inpatient sample (NIS) comparison report. In: HCUP methods series report 2007–03 online. US Agency for Healthcare Research and QualityGoogle Scholar
  10. 10.
    Kalra R, Patel N, Doshi R, Arora G, Arora P (2019) Evaluation of the incidence of new-onset atrial fibrillation after aortic valve replacement. JAMA Intern Med.  https://doi.org/10.1001/jamainternmed.2019.0205 CrossRefPubMedGoogle Scholar
  11. 11.
    Patel N, Gupta A, Doshi R, Kalra R, Bajaj NS, Arora G, Arora P (2019) In-hospital management and outcomes after ST-segment-elevation myocardial infarction in medicaid beneficiaries compared with privately insured individuals. Circ Cardiovasc Qual Outcomes 12(1):e004971.  https://doi.org/10.1161/CIRCOUTCOMES.118.004971 CrossRefPubMedGoogle Scholar
  12. 12.
    Patel N, Kalra R, Doshi R, Bajaj NS, Arora G, Arora P (2018) Trends and cost of heart transplantation and left ventricular assist devices: impact of proposed federal cuts. JACC Heart Fail 6(5):424–432.  https://doi.org/10.1016/j.jchf.2018.03.005 CrossRefPubMedGoogle Scholar
  13. 13.
    Bonow RO, Bennett S, Casey DE Jr, Ganiats TG, Hlatky MA, Konstam MA, Lambrew CT, Normand SL, Pina IL, Radford MJ, Smith AL, Stevenson LW, Bonow RO, Bennett SJ, Burke G, Eagle KA, Krumholz HM, Lambrew CT, Linderbaum J, Masoudi FA, Normand SL, Ritchie JL, Rumsfeld JS, Spertus JA, American College of C, American Heart Association Task Force on Performance M, Heart Failure Society of A (2005) ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 46(6):1144–1178.  https://doi.org/10.1016/j.jacc.2005.07.012 CrossRefPubMedGoogle Scholar
  14. 14.
    Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL (2015) Why summary comorbidity measures such as the charlson comorbidity index and Elixhauser score work. Med Care 53(9):e65–72.  https://doi.org/10.1097/MLR.0b013e318297429c CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Goyal P, Almarzooq ZI, Horn EM, Karas MG, Sobol I, Swaminathan RV, Feldman DN, Minutello RM, Singh HS, Bergman GW, Wong SC, Kim LK, Committee ASA, Investigators (2016) Characteristics of hospitalizations for heart failure with preserved ejection fraction. Am J Med 129(6):635.  https://doi.org/10.1016/j.amjmed.2016.02.007 CrossRefPubMedGoogle Scholar
  16. 16.
    Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP, ASA Committee Investigators (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the acute decompensated heart failure national registry (ADHERE). Am Heart J 149(2):209–216.  https://doi.org/10.1016/j.ahj.2004.08.005 CrossRefPubMedGoogle Scholar
  17. 17.
    Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, Young JB, Tang WHW (2009) Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol 53(7):589–596.  https://doi.org/10.1016/j.jacc.2008.05.068 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Metra M, Nodari S, Parrinello G, Bordonali T, Bugatti S, Danesi R, Fontanella B, Lombardi C, Milani P, Verzura G, Cotter G, Dittrich H, Massie BM, Dei Cas L (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10(2):188–195.  https://doi.org/10.1016/j.ejheart.2008.01.011 CrossRefPubMedGoogle Scholar
  19. 19.
    Forman DE, Butler J, Wang Y, Abraham WT, O'Connor CM, Gottlieb SS, Loh E, Massie BM, Rich MW, Stevenson LW, Young JB, Krumholz HM (2004) Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43(1):61–67CrossRefGoogle Scholar
  20. 20.
    Bansal N, Matheny ME, Greevy RA Jr, Eden SK, Perkins AM, Parr SK, Fly J, Abdel-Kader K, Himmelfarb J, Hung AM, Speroff T, Ikizler TA, Siew ED (2018) Acute kidney injury and risk of incident heart failure among US veterans. Am J Kidney Dis 71(2):236–245.  https://doi.org/10.1053/j.ajkd.2017.08.027 CrossRefPubMedGoogle Scholar
  21. 21.
    Go AS, Hsu CY, Yang J, Tan TC, Zheng S, Ordonez JD, Liu KD (2018) Acute kidney injury and risk of heart failure and atherosclerotic events. Clin J Am Soc Nephrol 13(6):833–841.  https://doi.org/10.2215/CJN.12591117 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Ronco C, Cicoira M, McCullough PA (2012) Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure. J Am Coll Cardiol 60(12):1031–1042.  https://doi.org/10.1016/j.jacc.2012.01.077 CrossRefPubMedGoogle Scholar
  23. 23.
    Bagshaw SM, Hoste EA, Braam B, Briguori C, Kellum JA, McCullough PA, Ronco C (2013) Cardiorenal syndrome type 3: pathophysiologic and epidemiologic considerations. Contrib Nephrol 182:137–157.  https://doi.org/10.1159/000349971 CrossRefPubMedGoogle Scholar
  24. 24.
    Di Lullo L, Reeves PB, Bellasi A, Ronco C (2019) Cardiorenal syndrome in acute kidney injury. Semin Nephrol 39(1):31–40.  https://doi.org/10.1016/j.semnephrol.2018.10.003 CrossRefPubMedGoogle Scholar
  25. 25.
    Lee SA, Cozzi M, Bush EL, Rabb H (2018) Distant organ dysfunction in acute kidney injury: a review. Am J Kidney Dis 72(6):846–856.  https://doi.org/10.1053/j.ajkd.2018.03.028 CrossRefPubMedGoogle Scholar
  26. 26.
    Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM (2006) Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47(10):1987–1996.  https://doi.org/10.1016/j.jacc.2005.11.084 CrossRefPubMedGoogle Scholar
  27. 27.
    Kang SH, Park JJ, Choi DJ, Yoon CH, Oh IY, Kang SM, Yoo BS, Jeon ES, Kim JJ, Cho MC, Chae SC, Ryu KH, Oh BH, Kor HFR (2015) Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF. Heart 101(23):1881–1888.  https://doi.org/10.1136/heartjnl-2015-307782 CrossRefPubMedGoogle Scholar
  28. 28.
    Takei M, Kohsaka S, Shiraishi Y, Goda A, Izumi Y, Yagawa M, Mizuno A, Sawano M, Inohara T, Kohno T, Fukuda K, Yoshikawa T, West Tokyo Heart Failure Registry I (2015) Effect of estimated plasma volume reduction on renal function for acute heart failure differs between patients with preserved and reduced ejection fraction. Circ Heart Fail 8(3):527–532.  https://doi.org/10.1161/CIRCHEARTFAILURE.114.001734 CrossRefPubMedGoogle Scholar
  29. 29.
    Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, O'Connor CM, Rich MW, Stevenson LW, Young J, Krumholz HM (2002) The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 8(3):136–141CrossRefGoogle Scholar
  30. 30.
    Waikar SS, Wald R, Chertow GM, Curhan GC, Winkelmayer WC, Liangos O, Sosa MA, Jaber BL (2006) Validity of international classification of diseases, ninth revision, clinical modification codes for acute renal failure. J Am Soc Nephrol 17(6):1688–1694.  https://doi.org/10.1681/ASN.2006010073 CrossRefPubMedGoogle Scholar

Copyright information

© Società Italiana di Medicina Interna (SIMI) 2019

Authors and Affiliations

  1. 1.Department of Internal MedicineUniversity of Nevada Reno School of MedicineRenoUSA

Personalised recommendations